09/15/2023 Edition 106
----- Division of Research -----
|
|
Understanding Drug Use and Overdose Risk |
|
The purpose of the Centers for Disease Control and Prevention National Center for Injury Prevention and Control (NCIPC) Mentored Research Scientist Development Award (K01) is to provide support for an intensive, supervised/mentored career development experience in substance use and/or overdose prevention research leading to research independence. NCIPC supports K01 grants to help ensure the availability of an adequate number of trained scientists to address critical public health research questions to prevent polydrug use and overdose. This funding would support research that aims to better understand and identify risk and protective factors related to any drug use/overdose (e.g., opioids including fentanyl and stimulants, etc.), substance use disorders (SUDs), and stigma (e.g., how do certain factors impact stigma). Research can focus on the examination of potential moderators or mediators between the relationship between risk and protective factors and drug use and outcomes. Research should be conducted among persons experiencing a disproportionate burden of substance use disorders and overdose, which may include but are not limited, to those people in certain sociodemographic groups (e.g. non-English speaking populations, tribal populations, rural communities, racial/ethnic minority groups, sexual and gender minority groups), people experiencing social determinants of health (e.g., reduced economic stability; limited educational attainment, access or quality; limited healthcare access or quality including those who have been historically underserved or are uninsured; limited access to substance use treatment; limited health literacy; those in geographically underserved areas), people experiencing social or physical health conditions or experiences (e.g., homelessness, a mental health condition, chronic pain, incarceration or recent release from incarceration, a disability, adverse childhood experiences, a history of suicidal ideation or suicide attempt, a history of substance use disorders and/or overdose).
Pre-application teleconference | October 10, 2023 | 2:00pm - 3:00pm EST
1-866-600-6035 | Use Passcode 23198543# when prompted
|
|
Interventions to Prevent Overdose |
|
CDC Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose, RFA-CE-24-012. CFDA #93.136. The maximum award amount will be $350,000 per award for the first 12-month budget period. This includes both direct and indirect costs. Applicants may request a project period of up to three (3) years. The maximum total project funding is $2,100,000 (direct and indirect) per award, over the project period. The project period is expected to be 09/30/2024 to 09/29/2027. Application Deadline: 12/01/2023.
The Centers for Disease Control and Prevention’s (CDC) National Center for Injury Prevention and Control (NCIPC, Injury Center) is soliciting investigator-initiated research to rigorously evaluate effectiveness of policies for reducing drug use and overdose as well as the effect of these strategies on reducing or worsening existing disparities in medical care and health outcomes. Equally important to quantifying the impacts of these policies on health outcomes is understanding their implementation and how implementation affects achieving the intended outcomes of the policy among groups experiencing disproportionate burden of overdose and/or groups that are at greater risk of experiencing adverse outcomes related to substance use due to social determinants of health.
The proposed research should evaluate the impact of a selected local, state, tribal, federal, or organizational policy (e.g., school or health systems) aimed at reducing or regulating substance use or reducing drug overdose, on rates of at least two overdose outcomes (i.e., nonfatal overdose, fatal overdose, substance use disorders, substance use, initiation of substance use among youth). The inclusion of social and structural determinants in outcome evaluations and implementation assessments can help to account for and better understand potential differential outcomes across population groups.
Pre-Application teleconference | October 17, 2023 | 2:00pm - 3:00pm EST
1-866-600-6035 | Use Passcode 23198543# when prompted
|
|
Strategies for Overdose Prevention |
|
The Centers for Disease Control and Prevention’s (CDC) National Center for Injury Prevention and Control (NCIPC, Injury Center) is soliciting investigator-initiated research to partner with communities to develop and rigorously evaluate the effectiveness of new, innovative, underdeveloped, or untested community-based strategies/interventions/ programs/practices to reduce overdose. Strategies/interventions/programs/practices may include but are not limited to, those that focus on preventing drug use initiation and drug use, reducing non-infectious harms related to drug use, reducing stigma or other barriers to harm reduction or substance use disorder treatment, and increasing linkage to and retention in care. Research should focus on groups experiencing a disproportionate burden of overdose and/or groups that are at greater risk of experiencing adverse outcomes related to substance use due to social determinants of health. Research should also involve engaging individuals in the focus population (e.g., people with lived experience with drug use).
Pre-Application teleconference | October 24, 2023 | 2:00pm - 3:00pm EST
1-866-600-6035 | Use Passcode 23198543# when prompted
|
|
Althea Sheets, Research, Scholarly, and Creative Activities Development Manager, Office of Sponsored Programs, althea.sheets@unlv.edu, 702-895-1880
|
|
|
|
|
|
|
|
